Durvalumab vs Metoprolol Succinate

## Durvalumab vs Metoprolol Succinate: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Metoprolol Succinate**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Metoprolol Succinate — N/A.

## Chemical Properties

**Type**: Durvalumab — Antibody; Metoprolol Succinate — Small molecule.